Your browser doesn't support javascript.
loading
DNA and modified vaccinia Ankara prime-boost vaccination generates strong CD8+ T cell responses against minor histocompatibility antigen HA-1.
Eldershaw, Suzy A; Pearce, Hayden; Inman, Charlotte F; Piper, Karen P; Abbotts, Ben; Stephens, Christine; Nicol, Samantha; Croft, Wayne; Powell, Richard; Begum, Jusnara; Taylor, Graham; Nunnick, Jane; Walsh, Donna; Sirovica, Mirjana; Saddique, Shamyla; Nagra, Sandeep; Ferguson, Paul; Moss, Paul; Malladi, Ram.
Affiliation
  • Eldershaw SA; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Pearce H; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Inman CF; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Piper KP; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Abbotts B; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Stephens C; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Nicol S; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Croft W; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Powell R; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Begum J; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Taylor G; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Nunnick J; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Walsh D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Sirovica M; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Saddique S; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Nagra S; Department of Haematology, Birmingham Health Partners, Queen Elizabeth Hospital, Birmingham, UK.
  • Ferguson P; Department of Haematology, Birmingham Health Partners, Queen Elizabeth Hospital, Birmingham, UK.
  • Moss P; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.
  • Malladi R; Department of Haematology, Birmingham Health Partners, Queen Elizabeth Hospital, Birmingham, UK.
Br J Haematol ; 195(3): 433-446, 2021 11.
Article in En | MEDLINE | ID: mdl-34046897
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Vaccinia virus / Viral Vaccines / T-Lymphocytes, Cytotoxic / Minor Histocompatibility Antigens / Vaccination / Vaccines, DNA / Graft vs Leukemia Effect / Antigens, Neoplasm Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2021 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Vaccinia virus / Viral Vaccines / T-Lymphocytes, Cytotoxic / Minor Histocompatibility Antigens / Vaccination / Vaccines, DNA / Graft vs Leukemia Effect / Antigens, Neoplasm Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2021 Type: Article Affiliation country: United kingdom